NYSE:ABBV - AbbVie News Headlines

Sign in or create an account to add this stock to your watchlist.
$92.26 -0.42 (-0.45 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$92.68
Today's Range$92.05 - $93.33
52-Week Range$83.19 - $125.86
Volume9.95 million shs
Average Volume7.26 million shs
Market Capitalization$137.83 billion
P/E Ratio16.48
Dividend Yield4.22%
Beta1.54

Headlines

AbbVie (NYSE ABBV) News Headlines

Source:
DateHeadline
Abbvie, AutoNation and E-Trade are the Yahoo Finance charts of the day.Abbvie, AutoNation and E-Trade are the Yahoo Finance charts of the day.
finance.yahoo.com - September 21 at 3:01 PM
European advisory group backs AbbVies Venclyxto + Roches Rituxan in CLLEuropean advisory group backs AbbVie's Venclyxto + Roche's Rituxan in CLL
seekingalpha.com - September 21 at 3:01 PM
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against AbbVie Inc. – ABBVEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against AbbVie Inc. – ABBV
www.marketwatch.com - September 21 at 3:01 PM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 21 at 3:01 PM
AbbVie Receives Positive CHMP Opinion for a Novel, Chemotherapy-free Combination of VENCLYXTO® (venetoclax tablets) with Rituximab as a Treatment with a Fixed Duration for Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior TherapyAbbVie Receives Positive CHMP Opinion for a Novel, Chemotherapy-free Combination of VENCLYXTO® (venetoclax tablets) with Rituximab as a Treatment with a Fixed Duration for Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy
www.prnewswire.com - September 21 at 7:36 AM
EU approves fifth copy of AbbVies $18 billion drug HumiraEU approves fifth copy of AbbVie's $18 billion drug Humira
www.reuters.com - September 20 at 3:03 PM
AbbVie Investigation: Bernstein Liebhard LLP Announces Investigation Of AbbVie Inc. - ABBVAbbVie Investigation: Bernstein Liebhard LLP Announces Investigation Of AbbVie Inc. - ABBV
finance.yahoo.com - September 20 at 3:03 PM
Company News For Sep 20, 2018Company News For Sep 20, 2018
finance.yahoo.com - September 20 at 3:03 PM
Mylan, Fujifilm win EU okay for copy of AbbVies HumiraMylan, Fujifilm win EU okay for copy of AbbVie's Humira
finance.yahoo.com - September 20 at 5:01 AM
AbbVie Inc (ABBV) Receives Consensus Recommendation of "Hold" from BrokeragesAbbVie Inc (ABBV) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 19 at 4:28 PM
Should AbbVie Be More Concerned About Its California Case for Humira?Should AbbVie Be More Concerned About Its California Case for Humira?
247wallst.com - September 19 at 3:10 PM
AbbVie shares fall after being sued by California over Humira allegationsAbbVie shares fall after being sued by California over Humira allegations
www.bizjournals.com - September 19 at 3:10 PM
Abbvie under pressure, AutoNation posting higher, E-Trade surgesAbbvie under pressure, AutoNation posting higher, E-Trade surges
finance.yahoo.com - September 19 at 3:10 PM
Investor Alert: Kaplan Fox Investigates AbbVie Inc.Investor Alert: Kaplan Fox Investigates AbbVie Inc.
finance.yahoo.com - September 19 at 3:10 PM
AbbVie shares fall after being sued over Humira allegationsAbbVie shares fall after being sued over Humira allegations
finance.yahoo.com - September 19 at 3:10 PM
AbbVie Faces California Insurance Department Suit for HumiraAbbVie Faces California Insurance Department Suit for Humira
finance.yahoo.com - September 19 at 3:10 PM
California insurance regulator sues AbbVie alleging Humira kickbacksCalifornia insurance regulator sues AbbVie alleging Humira kickbacks
www.reuters.com - September 19 at 6:31 AM
Californias insurance commissioner is suing AbbVie for using schemes to reward healthcare providers for prescribing Humira to patientsCalifornia's insurance commissioner is suing AbbVie for using schemes to reward healthcare providers for prescribing Humira to patients
www.businessinsider.com - September 19 at 6:31 AM
State claims drugmaker paid doctors to overprescribe HumiraState claims drugmaker paid doctors to overprescribe Humira
www.msn.com - September 19 at 6:31 AM
After-hours buzz: TLRY, FIT & moreAfter-hours buzz: TLRY, FIT & more
finance.yahoo.com - September 19 at 6:31 AM
Maker of Humira boosted sales of blockbuster drug through deceptive practices, California regulator allegesMaker of Humira boosted sales of blockbuster drug through deceptive practices, California regulator alleges
www.latimes.com - September 18 at 3:37 PM
Your Cancer Highlight: AbbVie Quietly Aims For A New Best-In-Class Approval In CLLYour Cancer Highlight: AbbVie Quietly Aims For A New Best-In-Class Approval In CLL
seekingalpha.com - September 18 at 3:17 PM
Commit To Purchase AbbVie At $47.50, Earn 2.7% Using OptionsCommit To Purchase AbbVie At $47.50, Earn 2.7% Using Options
www.nasdaq.com - September 18 at 3:17 PM
California sues AbbVie over alleged $1.2bn kickbacks to boost salesCalifornia sues AbbVie over alleged $1.2bn kickbacks to boost sales
www.ft.com - September 18 at 3:17 PM
California Sues AbbVie Over Alleged Arthritis Drug KickbacksCalifornia Sues AbbVie Over Alleged Arthritis Drug Kickbacks
finance.yahoo.com - September 18 at 3:17 PM
AbbVie shares fall after California insurance regulator sues company over alleged kickbacksAbbVie shares fall after California insurance regulator sues company over alleged kickbacks
www.cnbc.com - September 18 at 2:49 PM
The Zacks Analyst Blog Highlights: JPMorgan, Mastercard, AbbVie, CVS Health and Estee LauderThe Zacks Analyst Blog Highlights: JPMorgan, Mastercard, AbbVie, CVS Health and Estee Lauder
finance.yahoo.com - September 17 at 3:06 PM
AbbVie to Host Third-Quarter 2018 Earnings Conference CallAbbVie to Host Third-Quarter 2018 Earnings Conference Call
finance.yahoo.com - September 17 at 3:06 PM
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - September 24, 2018DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - September 24, 2018
finance.yahoo.com - September 17 at 3:06 PM
Roche's Child Arthritis Drug's New Formulation Gets FDA NodRoche's Child Arthritis Drug's New Formulation Gets FDA Nod
finance.yahoo.com - September 14 at 3:11 PM
3 Things You Might Be Overlooking With AbbVie3 Things You Might Be Overlooking With AbbVie
finance.yahoo.com - September 14 at 3:11 PM
Top Stock Reports for JPMorgan, Mastercard & AbbVieTop Stock Reports for JPMorgan, Mastercard & AbbVie
finance.yahoo.com - September 14 at 3:11 PM
Pharma/Biotech Stocks to Watch This Prostate Cancer MonthPharma/Biotech Stocks to Watch This Prostate Cancer Month
finance.yahoo.com - September 14 at 3:11 PM
AbbVies upadacitinib shows sustained treatment benefit in mid-stage dermatitis studyAbbVie's upadacitinib shows sustained treatment benefit in mid-stage dermatitis study
seekingalpha.com - September 13 at 3:08 PM
AbbVie Inc. -- Moodys assigns Baa2 to AbbVies sr. notes; stable outlookAbbVie Inc. -- Moody's assigns Baa2 to AbbVie's sr. notes; stable outlook
finance.yahoo.com - September 13 at 3:08 PM
AbbVie (ABBV) Says Minimal Residual Disease Negativity Data, a Measure of Undetectable Disease, Added to VENCLEXTA LabelAbbVie (ABBV) Says Minimal Residual Disease Negativity Data, a Measure of Undetectable Disease, Added to VENCLEXTA Label
www.streetinsider.com - September 12 at 3:09 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – September 24, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – September 24, 2018
finance.yahoo.com - September 12 at 3:09 PM
AbbVie Gets FDA Nod for Venclexta Label Expansion in LeukemiaAbbVie Gets FDA Nod for Venclexta Label Expansion in Leukemia
finance.yahoo.com - September 12 at 3:09 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FIZZ, RMTI, TTPH, ABBV and GDSThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FIZZ, RMTI, TTPH, ABBV and GDS
finance.yahoo.com - September 12 at 3:09 PM
AbbVie reaches tentative settlement in AndroGel litigationAbbVie reaches tentative settlement in AndroGel litigation
www.reuters.com - September 12 at 5:04 AM
MRD negativity data added to label of AbbVies VenclextaMRD negativity data added to label of AbbVie's Venclexta
seekingalpha.com - September 11 at 3:07 PM
AbbVie Inc (ABBV) Expected to Announce Quarterly Sales of $8.20 BillionAbbVie Inc (ABBV) Expected to Announce Quarterly Sales of $8.20 Billion
www.americanbankingnews.com - September 11 at 1:26 AM
Eli Lilly Initiates New Trial for Taltz in Plaque PsoriasisEli Lilly Initiates New Trial for Taltz in Plaque Psoriasis
finance.yahoo.com - September 10 at 3:02 PM
 Analysts Anticipate AbbVie Inc (ABBV) to Announce $2.01 EPS Analysts Anticipate AbbVie Inc (ABBV) to Announce $2.01 EPS
www.americanbankingnews.com - September 9 at 8:10 PM
Jim Cramer Weighs In On CarMax, AbbVie And MoreJim Cramer Weighs In On CarMax, AbbVie And More
finance.yahoo.com - September 7 at 3:10 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, ABBV and FBThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, ABBV and FB
finance.yahoo.com - September 7 at 3:09 PM
AbbVie Inc to Issue Quarterly Dividend of $0.96 (ABBV)AbbVie Inc to Issue Quarterly Dividend of $0.96 (ABBV)
www.americanbankingnews.com - September 7 at 12:29 PM
Top 5 Biotech Stocks for 2018Top 5 Biotech Stocks for 2018
finance.yahoo.com - September 6 at 5:08 AM
Public Voting is Open for the 2018 AbbVie CF Scholarship Thriving Student Awards, Given to Two Exceptional Students Living with Cystic FibrosisPublic Voting is Open for the 2018 AbbVie CF Scholarship Thriving Student Awards, Given to Two Exceptional Students Living with Cystic Fibrosis
www.bizjournals.com - September 5 at 3:10 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) and Lead Plaintiff Deadline – September 24, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) and Lead Plaintiff Deadline – September 24, 2018
finance.yahoo.com - September 5 at 3:10 PM
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel